European Archives - Page 946 of 983 - European Medical Journal

EMJ

New Oncotype DX® Data Presented at 2014 San Antonio Breast Cancer Symposium Further Demonstrate the Practice-Changing Impact of the Test in Guiding the Treatment of Early Stage Breast Cancer

GENEVA, Switzerland, [December 15, 2014] – Genomic Health announced presentation of the first prospective outcomes data from a large adjuvant study…

Risk Factors Associated With Asbestos-Related Diseases: Results of the Asbestos Surveillance Programme Aachen

The aim of this study was to examine the association between workplace exposure to asbestos and risk factors for developing related chronic respiratory…

Iron Overload: Causes, Consequences, And Control

The endeavours of physicians taxed with the problem of iron deficiency over the last 100 years have successfully eliminated this as an issue of…

Treatment Options for Obstructive Sleep Apnoea

Due to its prevalence, symptoms such as daytime sleepiness, increased risk of accidents, cardiovascular consequences, and the reduced prognosis…

Use of N-Terminal Natriuretic Peptide in a Real-World Setting Of Patients Admitted With Acute Dyspnoea and the Implication for Triaging Patients in the Emergency Department

The aim of this review is to determine, among patients admitted with dyspnoea, the proportion of patients that can be excluded from having acute…

Case Reports and Literature Review of Genital Psoriasis: Successful Therapy with Tacrolimus

Psoriasis is a chronic, inflammatory skin disease with a high prevalence in the general population. However, though psoriasis may involve all sites of…

Inherited Thrombocytopaenias: Beyond the Bleeding

The improvement of molecular biology technologies and the increasing number of researchers interested in inherited thrombocytopaenias (ITs) has led…

Understanding the Biology of Pulmonary Fibrosis: What Genes Tell Us for Idiopathic Interstitial Pneumonia

Pulmonary fibrosis is the formation of fibrous tissue as a reaction or a repair process in the lung.

EMJ

Gilead Presents Follow-Up Data from Idelalisib (Zydelig®) Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma

San Francisco, December 10, 2014 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced long-term follow-up results from the registration studies…

Case Report: Ventricular Fibrillation and Atrial Tachyarrhythmia in 4th Decade Restrictive Ventricular Septal Defect

Congenital cardiac patients have benefitted from the advent and refinement of corrective and palliative cardiac surgery and echocardiography.